Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study-Reference-Cited by-同舟云学术

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study

Published:2011-10-12 Issue:4 Volume:71 Page:541-548
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Baranauskaite Asta,Raffayová Helena,Kungurov NV,Kubanova Anna,Venalis Algirdas,Helmle Laszlo,Srinivasan Shankar,Nasonov Evgeny,Vastesaeger Nathan

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early psoriatic arthritis: clinical and therapeutic challenges;Expert Opinion on Investigational Drugs;2024-08-07

2. Comparative analysis of the treatment-naïve microbiome across rheumatic diseases to predict MTX treatment response;2024-07-31

3. Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis;The Journal of Rheumatology;2024-04-01

4. Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis;Advances in Rheumatology;2024-03-21

5. The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial;Therapeutic Advances in Musculoskeletal Disease;2024-01